

Aemetis vs Alto Ingredients
Aemetis focuses on advanced biofuels and renewable natural gas with a heavy development-stage profile, while Alto Ingredients runs established ethanol production facilities with a more immediate commercial revenue base. Both companies live and die by renewable fuel policy tailwinds and feedstock cost dynamics. The Aemetis vs Alto Ingredients comparison reveals how capital intensity, government subsidy dependency, and path to profitability differ between a growth-stage clean energy bet and a mature biofuels operator.
Aemetis focuses on advanced biofuels and renewable natural gas with a heavy development-stage profile, while Alto Ingredients runs established ethanol production facilities with a more immediate comme...
Investment Analysis

Aemetis
AMTX
Pros
- Aemetis has shown revenue growth with $59.2 million in Q3 2025, up $7 million from the prior quarter driven by India Oil Marketing Company orders and higher ethanol prices and volumes.
- The company is advancing a $30 million Mechanical Vapor Recompression system expected to increase cash flow by $32 million annually, enhancing operational efficiency.
- Aemetis operates diversified segments including renewable natural gas, ethanol, and biodiesel in the US and India, positioning it for growth in low and negative carbon intensity products.
Considerations
- Despite recent revenue growth, Aemetis has a relatively small market cap of approximately $144 million, indicating limited scale compared to larger energy peers.
- The company’s P/E ratio is negative, reflecting ongoing losses and the inherent execution risks in its expansion projects and technology commercialization.
- Aemetis operates in volatile renewable fuel markets and depends on regulatory policies and commodity prices, which pose macroeconomic uncertainties and cyclicality risks.

Alto Ingredients
ALTO
Pros
- Alto Ingredients generated $933 million in revenue over the past twelve months, reflecting a substantial scale in specialty alcohols and renewable fuel markets.
- The company serves diversified end markets including health, home, beauty, and food and beverage, reducing dependency on any single sector.
- Recent analyst sentiment shows a strong buy rating with a significant price target upside, indicating positive market expectations for turnaround potential.
Considerations
- Alto Ingredients reported a net loss exceeding $60 million in the latest twelve-month period, with losses more than doubling year-over-year, indicating strained profitability.
- The stock price has declined significantly from its 52-week high, reflecting investor concerns around sustainability of revenue and earnings.
- Revenue decreased by over 21% year-over-year, suggesting challenges in maintaining sales momentum amid competitive pressures and market fluctuations.
Buy AMTX or ALTO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


